All Stories

  1. Travel Distance and Its Impact on Wait Time for Positron Emission Tomography–Computed Tomography in Patients with Cancers

    Article • International Journal of Environmental Research and Public Health, December 2025, MDPI AG

    Dr. Dat Tran

  2. Travel Distance and Its Impact on Wait Time for Positron Emission Tomography–Computed Tomography in Patients with Cancers

    Article • June 2025, MDPI AG

    Dr. Dat Tran

  3. Healthcare resource use and costs associated with extreme heat in Alberta, Canada

    Article • Discover Health Systems, May 2025, Springer Science + Business Media

    Dr. Dat Tran

  4. Length of Stay and Home Discharge for Patients with Inpatient Stroke Rehabilitation

    Article • Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, October 2021, Cambridge University Press

    Dr. Dat Tran

  5. The Healthcare Cost Burden in Adults with High Risk for Cardiovascular Disease

    Article • PharmacoEconomics - Open, January 2021, Springer Science + Business Media

    Dr. Dat Tran

  6. Outcome and Cost of Optimal Control of Dyslipidemia in Adults With High Risk for Cardiovascular Disease

    Article • Canadian Journal of Cardiology, January 2021, Elsevier

    Dr. Dat Tran

  7. Lack of benefit from hospitalization in patients with syncope: A propensity analysis

    Article • Journal of the American College of Emergency Physicians Open, October 2020, Elsevier

    Dr. Dat Tran

  8. Assessment of Costs of Avoidable Delays in Intensive Care Unit Discharge

    Article • JAMA Network Open, August 2020, American Medical Association (AMA)

    Dr. Dat Tran

  9. The Current and Future Hospitalization Cost Burden of Syncope in Canada

    Article • CJC Open, July 2020, Elsevier

    Dr. Dat Tran

  10. A Population-Based Study Evaluating Sex Differences in Patients Presenting to Emergency Departments With Syncope

    Article • JACC Clinical Electrophysiology, March 2020, Elsevier

    Dr. Dat Tran

  11. Temporal Trends Of Pharmacologic Therapies For Patients With Chronic Obstructive Pulmonary Disease In Alberta, Canada

    Article • International Journal of Chronic Obstructive Pulmonary Disease, September 2019, Taylor & Francis

    Dr. Dat Tran

  12. The Costs of Industry-Sponsored Drug Trials in Canada

    Article • PharmacoEconomics - Open, July 2019, Springer Science + Business Media

    Dr. Dat Tran

  13. Publicly funded clinical research in Canada

    Article • Healthcare Management Forum, July 2019, SAGE Publications

    Dr. Dat Tran

  14. Current and future direct healthcare cost burden of chronic obstructive pulmonary disease in Alberta, Canada

    Article • Canadian Journal of Respiratory Critical Care and Sleep Medicine, July 2019, Taylor & Francis

    Dr. Dat Tran

  15. Total and Cause-Specific Mortality After Percutaneous Coronary Intervention: Observations From the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease Registry

    Article • CJC Open, July 2019, Elsevier

    Dr. Dat Tran

  16. A Population-Based Study of Device Eligibility, Use, and Reasons for Nonimplantation in Patients at Heart Function Clinics

    Article • CJC Open, July 2019, Elsevier

    Dr. Dat Tran

  17. Association between strained ICU capacity and healthcare costs in Canada: A population-based cohort study

    Article • Journal of Critical Care, June 2019, Elsevier

    Dr. Dat Tran

  18. The Costs of Industry-Sponsored Medical Device Clinical Trials in Alberta

    Article • PharmacoEconomics - Open, April 2019, Springer Science + Business Media

    Dr. Dat Tran

  19. Incremental costs of high intensive care utilisation in patients hospitalised with heart failure

    Article • European Heart Journal Acute Cardiovascular Care, April 2019, SAGE Publications

    Dr. Dat Tran

  20. Health Care Resource Utilization Among Children With Congenital Heart Disease: A Population-Based Study

    Article • Canadian Journal of Cardiology, October 2018, Elsevier

    Dr. Dat Tran

  21. Resource Use and Burden of Hospitalization, Outpatient, Physician, and Drug Costs in Short- and Long-term Care After Acute Myocardial Infarction

    Article • Canadian Journal of Cardiology, October 2018, Elsevier

    Dr. Dat Tran

  22. The high cost of critical care unit over-utilization for patients with NSTE ACS

    Article • American Heart Journal, August 2018, Elsevier

    Dr. Dat Tran

  23. A Population-Based Study Evaluating Differences in Admission Rates and Outcomes Between Men and Women Presenting to Emergency Departments with a Primary Diagnosis of Syncope

    Article • Canadian Journal of Cardiology, April 2018, Elsevier

    Dr. Dat Tran

  24. A Population-Based Study of Syncope in the Young

    Article • Canadian Journal of Cardiology, February 2018, Elsevier

    Dr. Dat Tran

  25. A Population-Based Cohort Study Evaluating Outcomes and Costs for Syncope Presentations to the Emergency Department

    Article • JACC Clinical Electrophysiology, February 2018, Elsevier

    Dr. Dat Tran

  26. The Economic Contribution of Industry-Sponsored Pharmaceutical Clinical Trials

    Article • Journal of Pharmacy & Pharmaceutical Sciences, November 2017, University of Alberta Libraries

    Dr. Dat Tran

  27. The Healthcare Cost Burden of Acute Myocardial Infarction in Alberta, Canada

    Article • PharmacoEconomics - Open, November 2017, Springer Science + Business Media

    Dr. Dat Tran

  28. Quality of Acute Myocardial Infarction Care in Canada: A 10-Year Review of 30-Day In-Hospital Mortality and 30-Day Hospital Readmission

    Article • Canadian Journal of Cardiology, October 2017, Elsevier

    Dr. Dat Tran

  29. RELATIVE BURDEN OF HOSPITALIZATION, OUTPATIENT, PHYSICIAN, AND DRUG COSTS IN THE SHORT- AND LONG-TERM AFTER ACUTE MYOCARDIAL INFARCTION

    Article • Canadian Journal of Cardiology, October 2017, Elsevier

    Dr. Dat Tran

  30. Assessing physician knowledge regarding indications for a primary prevention implantable defibrillator and potential barriers for referral

    Article • Journal of Cardiovascular Electrophysiology, September 2017, Wiley

    Dr. Dat Tran

  31. Cost of Congenital Heart Disease Hospitalizations in Canada: A Population-Based Study

    Article • Canadian Journal of Cardiology, June 2017, Elsevier

    Dr. Dat Tran

  32. Temporal Trends of Reperfusion Strategies and Hospital Mortality for Patients With STEMI in Percutaneous Coronary Intervention–Capable Hospitals

    Article • Canadian Journal of Cardiology, April 2017, Elsevier

    Dr. Dat Tran

  33. Authors’ Reply to Holko: “Forecasting Pharmaceutical Prices for Economic Evaluations When There Is No Market: A Review”

    Article • PharmacoEconomics - Open, January 2017, Springer Science + Business Media

    Dr. Dat Tran

  34. Comment on: “Forecasting Pharmaceutical Prices for Economic Evaluations When There is No Market: A Review”

    Article • PharmacoEconomics - Open, January 2017, Springer Science + Business Media

    Dr. Dat Tran

  35. Forecasting Pharmaceutical Prices for Economic Evaluations When There Is No Market: A Review

    Article • PharmacoEconomics - Open, November 2016, Springer Science + Business Media

    Dr. Dat Tran

  36. The current and future financial burden of hospital admissions for heart failure in Canada: a cost analysis

    Article • CMAJ Open, July 2016, Canadian Medical Association (CMA)

    Dr. Dat Tran

  37. Cost Effectiveness of Eplerenone for the Treatment of Systolic Heart Failure with Mild Symptoms in Alberta, Canada

    Article • American Journal of Cardiovascular Drugs, June 2016, Springer Science + Business Media

    Dr. Dat Tran

  38. Utilization of HIV Voluntary Counseling and Testing in Vietnam: An Evaluation of 5 Years of Routine Program Data for National Response

    Article • AIDS Education and Prevention, June 2011, Guilford Publications

    Dr. Dat Tran